Screening Tool Could up Hepatocellular Carcinoma Survival to 90%
A new machine-learning serum fusion-gene model shows promise in increasing hepatocellular carcinoma diagnostic accuracy and monitoring.
Read MorePosted by Chris Wolski | Jun 28, 2024 | Unknown Origin & Other Cancer Types |
A new machine-learning serum fusion-gene model shows promise in increasing hepatocellular carcinoma diagnostic accuracy and monitoring.
Read MorePosted by Chris Wolski | Jun 28, 2024 | POC Reagents & Test Kits |
The FDA has authorized Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first point-of-care HCV test for certified settings.
Read MorePosted by Andy Lundin | Jun 27, 2024 | Tuberculosis |
QIAGEN supports new guidelines recommending the screening of at-risk children of all ages for latent tuberculosis using advanced blood tests.
Read MorePosted by Chris Wolski | Jun 17, 2024 | Emerging & Zoonotic Diseases |
H5N1 avian flu, historically infecting birds, has recently infected three farm workers. Diagnostic testing may be our best defense.
Read MorePosted by Andy Lundin | Jun 14, 2024 | Infectious Diseases |
Co-Diagnostics completed its first FDA application for 510(k) clearance for the Co-Dx PCR Pro instrument and the Co-Dx PCR COVID-19 Test.
Read More